Replies to post #54980 on Ariad Pharmaceuticals Inc fka ARIA

[biotech_researcher]

This is good, but is for Accelerated Phase patients, who are on their last leg, and fortunately for patients, relatively small numbers.

[gr8db8]

Note the FL CML-AP trial is for 30 mg and requires that "Patients must have received no or minimal prior therapy". (Prior use of hydroxyurea or anagrelide is allowed with no limitations.)